Disrupting the High Price of Generic Drugs

Civica Rx is the brainchild of hospitals and health systems that formed a collaborative to hold down the spiraling costs of essential generic drugs. How is the plan working out? Civica Rx President and CEO Martin VanTrieste shares an update on the organization’s efforts on a new AHA Advancing Health podcast.

 

 

Listen to More Advancing Health Podcasts

Related Resources

AHA Center for Health Innovation Market Scan
*/ /*-->*/ With rising prices for insulin and the costs of many other diabetes-related drugs taking their toll on patients, CVS Health recently announced…
Letter/Comment
Letter/Comment
Public
The AHA today submitted comments to House leaders on the Lower Drug Costs Now Act (H.R. 3), legislation that would make a series of changes to the Medicare…
AHA Center for Health Innovation Market Scan
*/ /*-->*/ In what is being hailed as a model for provider-led innovation, Civica Rx, the startup formed last year by a group of health systems to combat…
AHA Center for Health Innovation Market Scan
*/ /*-->*/ With all of Amazon’s health care moves, it’s been tough to get a precise read on exactly where the company is headed. But when it comes to…
Public
Individuals, employers, government and payers are seeking greater value for their health care dollars. Concerns around the affordability of health care will…